← back to search

Sirano Dhe‐Paganon

Neuroendocrine Tumor Research Foundation ·
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, and Signaling Pathways in Disease.
h-index
61
citations
14,185
works
326
NIH funding
primary concept
email

Recent publications

Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma
Molecular Cell 2025cited by 13position: middledoi
Redox regulation of m6A methyltransferase METTL3 in β-cells controls the innate immune response in type 1 diabetes
Nature Cell Biology 2024cited by 47position: middledoi
The human zinc-binding cysteine proteome
Cell 2024cited by 41position: middledoi
Lactate regulates cell cycle by remodelling the anaphase promoting complex
Nature 2023cited by 195position: middledoi
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease
Nature Medicine 2023cited by 144position: middledoi
Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor
Nature Chemical Biology 2023cited by 46position: middledoi
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity
Cell 2022cited by 120position: middledoi
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Science Translational Medicine 2022cited by 109position: middledoi
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma
Cancer Discovery 2022cited by 62position: middledoi
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism
Scientific Reports 2020cited by 121position: middledoi
Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy
Cell 2020cited by 97position: middledoi
Discovery and Structure–Activity Relationship Study of ( <i>Z</i> )-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors
Journal of Medicinal Chemistry 2020cited by 29position: middledoi
Structural and functional consequences of the STAT5BN642H driver mutation
Nature Communications 2019cited by 84position: middledoi
Islet-Derived eATP Fuels Autoreactive CD8+ T Cells and Facilitates the Onset of Type 1 Diabetes
Diabetes 2018cited by 29position: middledoi
Transcription control by the ENL YEATS domain in acute leukaemia
Nature 2017cited by 325position: middledoi
Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands
Angewandte Chemie International Edition 2017cited by 289position: middledoi
MELK is not necessary for the proliferation of basal-like breast cancer cells
eLife 2017cited by 194position: middledoi
Data publication with the structural biology data grid supports live analysis
Nature Communications 2016cited by 132position: middledoi
Phthalimide conjugation as a strategy for in vivo target protein degradation
Science 2015cited by 1,708position: middledoi
A Strategy for Modulation of Enzymes in the Ubiquitin System
Science 2013cited by 296position: middledoi
A Human Ubiquitin Conjugating Enzyme (E2)-HECT E3 Ligase Structure-function Screen
Molecular & Cellular Proteomics 2012cited by 130position: lastdoi
Two ZnF-UBP Domains in Isopeptidase T (USP5)
Biochemistry 2012cited by 63position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Hyuk‐Soo Seo · Harvard University10 papers (2017–2025)Dennis L. Buckley · Novartis (China)4 papers (2015–2017)James E. Bradner · Novartis (China)4 papers (2015–2017)Joshiawa Paulk · Novartis (United States)4 papers (2015–2017)Justin M. Roberts · Whitehead Institute for Biomedical Research3 papers (2015–2017)Shiva Dastjerdi · Boston University3 papers (2017–2017)Tinghu Zhang · Stanford University3 papers (2017–2023)Georg E. Winter · Austrian Academy of Sciences3 papers (2015–2017)Nathanael S. Gray · Stanford University3 papers (2017–2023)Edward T. Chouchani · Harvard University2 papers (2023–2024)Haopeng Xiao · Stanford University2 papers (2023–2024)Lewis C. Cantley · Meyer (China)2 papers (2020–2023)Jianwei Che · Harvard University2 papers (2023–2024)Narek Darabedian · University of California, Riverside2 papers (2023–2024)Amanda Souza · Australasian Leukaemia and Lymphoma Group2 papers (2015–2017) · 2 papers (2012–2012) · 2 papers (2012–2012)Behnam Nabet · Fred Hutch Cancer Center2 papers (2017–2017)John R. Walker · McMaster University2 papers (2012–2012)Patrick T. Gunning · Queen's University1 papers (2019–2019)